5/13/2014

Type 2 diabetes patients who took incretin-based drugs had a similar risk profile for acute pancreatitis as those who were on sulfonylurea treatment, according to a study in BMJ. Researchers said the findings, though consistent with other studies, warrant further assessment.

Related Summaries